ROLE OF 18F-FACBC PET/CT IN NODALSTAGING FOR HIGH-RISK PROSTATE CANCER: PRELIMINARY ANALYSIS

被引：0
|
作者：
Borghesi, Marco [1 ]
Schiavina, Riccardo [1 ]
Angiolini, Andrea [1 ]
Bianchi, Federico Mineo [1 ]
Bianchi, Lorenzo [1 ]
Fiorentino, Michelangelo [2 ]
Pultrone, Cristian [1 ]
Zanoni, Lucia [3 ]
Fanti, Stefano [3 ]
Martorana, Giuseppe [1 ]
Brunocilla, Eugenio [1 ]
机构：
[1] Univ Bologna, Div Urol, St Orsola Malpighi Hosp, Bologna, Italy
[2] Univ Bologna, Div Anat Pathol, St Orsola Malpighi Hosp, Bologna, Italy
[3] Univ Bologna, Div Nucl Med, St Orsola Malpighi Hosp, Bologna, Italy
来源：
ANTICANCER RESEARCH | 2017年 / 37卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
16
引用
收藏
页码：2061 / 2062
页数：2
相关论文
共 50 条
  • [31] Imaging characteristics of [18F]GE-148 ([18F]FACBC) PET/CT in subjects with prostate cancer
    Sorensen, Jens
    Johansson, Silvia
    Owenius, Rikard
    Lax, Michelle
    JOURNAL OF NUCLEAR MEDICINE, 2010, 51
  • [32] Deep learning detection of prostate cancer recurrence with 18F-FACBC (fluciclovine, Axumin®) positron emission tomography
    Jong Jin Lee
    Hongye Yang
    Benjamin L. Franc
    Andrei Iagaru
    Guido A. Davidzon
    European Journal of Nuclear Medicine and Molecular Imaging, 2020, 47 : 2992 - 2997
  • [33] Impact of 18F-PSMA-11 PET/CT on Management of Biochemical Recurrence and High-Risk Prostate Cancer Staging18F-PSMA-11 PET/CT and Impact on Prostate Cancer Management
    Kathia De Man
    Sarah Piron
    Nick Van Laeken
    Louke Delrue
    Valérie Fonteyne
    Nicolaas Lumen
    Bliede Van den Broeck
    Ken Kersemans
    Piet Ost
    Vanessa Schelfhout
    Molecular Imaging and Biology, 2022, 24 : 750 - 758
  • [34] Impact of 18F-PSMA-11 PET/CT on Management of Biochemical Recurrence and High-Risk Prostate Cancer Staging 18F-PSMA-11 PET/CT and Impact on Prostate Cancer Management
    De Man, Kathia
    Piron, Sarah
    Van Laeken, Nick
    Delrue, Louke
    Fonteyne, Valerie
    Lumen, Nicolaas
    Van den Broeck, Bliede
    Kersemans, Ken
    Ost, Piet
    Schelfhout, Vanessa
    MOLECULAR IMAGING AND BIOLOGY, 2022, 24 (05) : 750 - 758
  • [35] A prospective study on dual time 18 F-FDG-PET/CT in high-risk prostate cancer patients
    Mortensen M.A.
    Vilstrup M.H.
    Poulsen M.H.
    Gerke O.
    Høilund-Carlsen P.F.
    Lund L.
    BMC Research Notes, 11 (1)
  • [36] Role of 18F-Choline PET/CT in high-risk DTC patients. Comparison with 18F-FDG PET/CT
    Dib, B.
    Bottoni, G.
    Foppiani, L.
    Altrinetti, V.
    Massollo, M.
    Massollo, M.
    Cabria, M.
    Piccardo, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S367 - S367
  • [37] EVALUATION OF FLUCICLOVINE (FACBC) PET SCAN FOR STAGING HIGH-RISK PROSTATE CANCER BEFORE PRIMARY TREATMENT
    Alemozaffar, Mehrdad
    Akintayo, Akinyemi
    Abiodun-Ojo, Olayinka
    Huang, Eugene
    Patil, Dattatraya
    Giles, Stephanie
    Torlak, Mersiha
    Sanda, Martin
    Schuster, David
    JOURNAL OF UROLOGY, 2019, 201 (04): : E396 - E396
  • [38] Outcome of PET/CT 18F-Choline in high risk prostate cancer patients
    Lavados, H.
    Pruzzo, R.
    Amaral, H.
    Hernandez, E.
    Morales, B.
    Haeger, A.
    Fernandez, R.
    Hurtado, A.
    Galaz, R.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S435 - S435
  • [39] 18F-FACBC (anti1-amino-3-18F-fluorocyclobutane-1-carboxylic acid) versus 11C-choline PET/CT in prostate cancer relapse: results of a prospective trial
    Nanni, Cristina
    Zanoni, Lucia
    Pultrone, Cristian
    Schiavina, Riccardo
    Brunocilla, Eugenio
    Lodi, Filippo
    Malizia, Claudio
    Ferrari, Matteo
    Rigatti, Patrizio
    Fonti, Cristina
    Martorana, Giuseppe
    Fanti, Stefano
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 (09) : 1601 - 1610
  • [40] 18F-FACBC (anti1-amino-3-18F-fluorocyclobutane-1-carboxylic acid) versus 11C-choline PET/CT in prostate cancer relapse: results of a prospective trial
    Cristina Nanni
    Lucia Zanoni
    Cristian Pultrone
    Riccardo Schiavina
    Eugenio Brunocilla
    Filippo Lodi
    Claudio Malizia
    Matteo Ferrari
    Patrizio Rigatti
    Cristina Fonti
    Giuseppe Martorana
    Stefano Fanti
    European Journal of Nuclear Medicine and Molecular Imaging, 2016, 43 : 1601 - 1610
12345